Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability
PDB DOI: 10.2210/pdb7lcs/pdb
Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2
Deposited: 2021-01-11 Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Young, H.S.
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability
Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Young, H.S.
Primary Citation of Related Structures: 7LCS
Proteins | ||||
---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Sequence |
3C-like proteinase | A | 306 | Severe Acute Respiratory Syndrome Coronavirus 2 | SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQ |
Method: X-RAY DIFFRACTION
Deposited Date: 2021-01-11 Deposition Author(s): Arutyunova, E. , Khan, M.B. , Lemieux, M.J. , Young, H.S.